Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shanghai Shen Lian Biomedical's Dividend Yield % or its related term are showing as below:
During the past 13 years, the highest Dividend Yield of Shanghai Shen Lian Biomedical was 1.92%. The lowest was 0.00%. And the median was 0.93%.
SHSE:688098's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.34 * Ranked among companies with meaningful Dividend Yield % only.
During the past 12 months, Shanghai Shen Lian Biomedical's average Dividends Per Share Growth Rate was -100.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Shanghai Shen Lian Biomedical (SHSE:688098) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shen Lian Biomedical Dividend Yield % Chart
SHSE:688098 vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, Shanghai Shen Lian Biomedical's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Shen Lian Biomedical Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Shen Lian Biomedical's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Shanghai Shen Lian Biomedical's Dividend Yield % falls into.
Shanghai Shen Lian Biomedical (SHSE:688098) has a Dividend Yield % of 0.00% as of Jul. 22, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Shanghai Shen Lian Biomedical and its competitors. According to the industry distribution chart, Shanghai Shen Lian Biomedical ranks #999999 out of 153 companies in the Biotechnology industry.
Is Shanghai Shen Lian Biomedical's Dividend Yield % too high?
Shanghai Shen Lian Biomedical's current Dividend Yield % is 0.00%. Based on the distribution chart, Shanghai Shen Lian Biomedical ranks #999999 out of 153 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Shanghai Shen Lian Biomedical has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shen Lian Biomedical's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Shen Lian Biomedical ranks #999999 out of 153 companies for Dividend Yield %. This places Shanghai Shen Lian Biomedical in the lower half of its industry. The industry median Dividend Yield % is 1.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.34, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Shanghai Shen Lian Biomedical and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Shen Lian Biomedical's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shen Lian Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shen Lian Biomedical (SHSE:688098) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥5.86, compared to a current price of ¥8.34 — trading 42.3% above its estimated fair value. The current Dividend Yield % is 0.00%. Shanghai Shen Lian Biomedical's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Shanghai Shen Lian Biomedical (SHSE:688098), the current Dividend Yield % is 0.00% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Shen Lian Biomedical (SHSE:688098) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Shen Lian Biomedical stock appears to be overvalued.
The current stock price of ¥8.34 is trading 42.3% above its estimated GF Value™ of ¥5.86.
GuruFocus considers Shanghai Shen Lian Biomedical to be Significantly Overvalued.
Key valuation signals for SHSE:688098:
Dividend Yield %: 0.00%
GF Value™: ¥5.86 vs. price of ¥8.34 (42.3% above fair value)
No single metric tells the full story. See the SHSE:688098 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Shen Lian Biomedical Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688098 has been successfully added to your 
